Expertise in
4
conditions

Gaetan Plantefeve

Argenteuil, FR 
Expertise in
4
conditions
Argenteuil, FR 
OverviewLocationsClinical Research

Overview

Gaetan Plantefeve practices in Argenteuil, France. Mr. Plantefeve is highly rated in 4 conditions, according to our data. His top areas of expertise are Pneumonia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Acute Respiratory Distress Syndrome (ARDS).

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Argenteuil, France
Other Locations
Roubaix, France
Lyon, 86000, France
Dieppe, France
Limoges, France
Le Mans, France
Annecy, France
Brive-la-gaillarde, France
INSERM CIC 1402, And CIC 1435, Point A-Pitre All In France, Montauban, France
La Roche, France
Saint Brieuc, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug
Study Drug: Dobutamine
Study Phase: Phase 3
Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure: A Multicentre, Open-label, Pragmatic, Randomised, Non-inferiority Controlled Trial (EVERDAC Trial)
Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure: A Multicentre, Open-label, Pragmatic, Randomised, Non-inferiority Controlled Trial (EVERDAC Trial)
Enrollment Status: Completed
Publish Date: May 04, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
Double-blinded Multicenter Randomized Controlled Trial Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
Double-blinded Multicenter Randomized Controlled Trial Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Drug
Study Drug: Amikacin
Study Phase: Phase 3
Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Other
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Biological, Other
Study Drug: Cx611
Study Phase: Phase 1/Phase 2
Phase 3 Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients With Sepsis-associated Acute Kidney Injury (SA-AKI)
Phase 3 Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients With Sepsis-associated Acute Kidney Injury (SA-AKI)
Enrollment Status: Terminated
Publish Date: October 12, 2021
Intervention Type: Drug
Study Phase: Phase 3
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Other
Study Phase: Not Applicable
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Enrollment Status: Completed
Publish Date: August 14, 2019
Intervention Type: Other
Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study
Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study
Enrollment Status: Completed
Publish Date: May 23, 2019
Intervention Type: Procedure
Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm at Rescue Arrival: The HYPERION Study
Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm at Rescue Arrival: The HYPERION Study
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 11 Less Clinical Trials

90 Total Publications

Deferring Arterial Catheterization in Critically Ill Patients with Shock.
Deferring Arterial Catheterization in Critically Ill Patients with Shock.
Journal: The New England journal of medicine
Published: October 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Plantefeve's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile